# daptomycin

NDC: 67457-813
Generic name: daptomycin
Labeler / Manufacturer: Mylan Institutional LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes: INTRAVENOUS
Marketing started: 20180904

FDA application: ANDA205037

## Active ingredients

- DAPTOMYCIN: 500 mg/10mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"67457-813"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=67457-813
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b7737862-e783-4af3-9521-ae00ed7a42aa